Immunology Research and Immunotherapy is an online, peer-review, open-access journal which aims at publishing the most dependable data based on recent advances, clinical trials and emergency scenarios. Our peer-review process ensures that the manuscripts are thoroughly reviewed before being published. This process helps us in setting our benchmark standard. Immunology Research and Immunotherapy publishes original research, review articles, case studies, editorials, short communication, brief reports, conference reports, opinions, perspectives, abstracts and proceedings, and clinical images.
Immunology Research and Immunotherapy offers extremely simple and user-friendly techniques to submit the manuscript. We have reviewers who directly download articles online and give their feedback. You can contact us at the Email address given below. Our Editorial Tracking System provides safe and secure usage. Once the article is ready to get published, the author/s is contacted for further information.
This Journal commenced publication in 2024, adopts an online publication format. With a frequency of two issues per year, the journal ensures a rigorous review process to uphold the utmost standards of quality and relevance in its published content. By allowing for longer intervals between issues, the journal can effectively address emerging trends, challenges, and innovations in healthcare and advanced nursing. This approach contributes significantly to the advancement of the field by providing practitioners and researchers with valuable insights and evidence-based knowledge.
Authors may submit manuscripts as an email attachment to the Editorial Office at immunology@scitechjournals.org or submit the manuscript online at Immunology Research and Immunotherapy
The scope of the journal broadly covers topics under Immunotherapy such as: Monoclonal antibodies, Immune checkpoint inhibitors, Non-specific immunotherapies, Oncolytic virus therapy, T-cell therapy, Cancer vaccines, Mesothelioma, Multiple myeloma, Non-Hodgkin lymphoma, Prostate cancer, Soft tissue sarcoma, Stomach cancer.
